By incorporating appropriate drug (s) into lipid (biobased) nanocarriers, one obtains a
combination therapeutic for dementia treatment that targets certain cell-surface scavenger …

Abstract Aging, hypertension, diabetes, obesity, atherosclerosis, traumatic brain injury, and
other factors can all synergistically promote diverse pathological mechanisms. These risk …

Neurodegenerative disorders encompass diseases that involve the degeneration of
neurons, particularly those within the central nervous system. These are the most commonly …

Much evidence has been published which indicates that microvascular endothelial
dysfunction, due to cerebrovascular risk factors (eg, atherosclerosis, hypertension, obesity …

Past published studies have already documented that, subsequent to the intravenous
injection of colloidal lipid nanocarriers, apolipoprotein (apo) AI is adsorbed from the blood …

Early changes in systemic vascular stiffness and endothelial function can contribute to
altered cerebrovascular hemodynamics and impaired cognitive function; additionally, these …

Alzheimer's disease (AD) is very common type of disorder like dementia.
Neurodegeneration that is pathophysiologically progressive is a hallmark of the AD. Amyloid …

Over the past decades, a frequent co-morbidity of cerebrovascular pathology and
Alzheimer's disease has been observed. Numerous published studies indicate that the …

Neurodegenerative disorders such as “Alzheimer's disease”(AD) are the main preliminary
cause for dementia, which involves around 60–80% of all dementia cases. AD is a …

The administration of promising medications for the treatment of neurodegenerative
disorders (NDDs), such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's …